Lazard Asset Management
TMDX icon

Lazard Asset Management’s Transmedics TMDX Stock Holding History

Lazard Asset Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.44M Buy
64,794
+13,385
+26% +$1.75M 0.01% 505
2025
Q4 		$6.25M Sell
51,409
-19,143
-27% -$2.4M 0.01% 501
2025
Q3 		$7.92M Buy
70,552
+51,973
+280% +$6.08M 0.01% 474
2025
Q2 		$2.49M Sell
18,579
-27,286
-59% -$3M ﹤0.01% 938
2025
Q1 		$3.08M Sell
45,865
-131
-0.3% -$9.01K ﹤0.01% 833
2024
Q4 		$2.87M Buy
45,996
+12,583
+38% +$1.17M ﹤0.01% 769
2024
Q3 		$5.25M Buy
33,413
+2,345
+8% +$361K 0.01% 619
2024
Q2 		$4.68M Sell
31,068
-18,503
-37% -$2.22M 0.01% 688
2024
Q1 		$3.67M Sell
49,571
-14,865
-23% -$1.23M ﹤0.01% 734
2023
Q4 		$5.08M Sell
64,436
-9,286
-13% -$560K 0.01% 680
2023
Q3 		$4.04M Buy
73,722
+73,192
+13,810% +$5.27M 0.01% 740
2023
Q2 		$44K Hold
530
– – ﹤0.01% 1878
2023
Q1 		$40K Buy
+530
New +$36.7K ﹤0.01% 1865
2021
Q4 		– Sell
-1,133
Closed -$37K – 2462
2021
Q3 		$37K Buy
+1,133
New +$34.6K ﹤0.01% 1820
2021
Q2 		– Sell
-797
Closed -$33K – 2074
2021
Q1 		$33K Buy
+797
New +$24.5K ﹤0.01% 1624

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lazard Asset Management's TMDX Position: Q1 2026 in Review

Lazard Asset Management increased its Transmedics (TMDX) stake by 26% in Q1 2026, buying an estimated $1.75M and bringing the position to 64,794 shares worth $6.44M. The position accounts for 0.01% of the portfolio, ranked #505.

Lazard Asset Management first reported a position in TMDX in Q1 2021 and has held it in 15 quarters since. The position peaked at $7.92M in Q3 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Lazard Asset Management held 64,794 shares of Transmedics worth $6.44M as of Q1 2026.
  • Lazard Asset Management bought 13,385 Transmedics shares in Q1 2026, an estimated $1.75M.
  • Transmedics made up 0.01% of Lazard Asset Management's portfolio in Q1 2026, its #505 holding.
  • Lazard Asset Management first reported a position in Transmedics in Q1 2021 and has held it in 15 quarters since.
  • Lazard Asset Management's Transmedics position peaked at $7.92M in Q3 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.